Erkki Nissinen

2.6k total citations
61 papers, 2.1k citations indexed

About

Erkki Nissinen is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Erkki Nissinen has authored 61 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Physiology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Erkki Nissinen's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Nitric Oxide and Endothelin Effects (7 papers) and Biochemical and Molecular Research (7 papers). Erkki Nissinen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Nitric Oxide and Endothelin Effects (7 papers) and Biochemical and Molecular Research (7 papers). Erkki Nissinen collaborates with scholars based in Finland, United States and United Kingdom. Erkki Nissinen's co-authors include Inge‐Britt Lindén, Pekka T. Männistö, Eija Schultz, Seppo Kaakkola, P Pohto, Bohdan Bakay, Heimo Haikala, Jouko Levijoki, William L. Nyhan and Juha Kaivola and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Pain.

In The Last Decade

Erkki Nissinen

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erkki Nissinen Finland 27 747 458 361 315 209 61 2.1k
Mitsuyoshi Nakashima Japan 30 863 1.2× 803 1.8× 314 0.9× 276 0.9× 298 1.4× 204 3.2k
R Warzok Germany 28 504 0.7× 130 0.3× 264 0.7× 301 1.0× 159 0.8× 103 2.9k
J. R. Bianchine United States 21 292 0.4× 595 1.3× 290 0.8× 191 0.6× 97 0.5× 49 1.8k
D. P. R. Muller United Kingdom 35 1.1k 1.5× 190 0.4× 225 0.6× 253 0.8× 140 0.7× 106 3.4k
Bart Marescau Belgium 32 566 0.8× 187 0.4× 177 0.5× 298 0.9× 86 0.4× 80 2.5k
Samuel M. Poloyac United States 36 940 1.3× 157 0.3× 790 2.2× 160 0.5× 560 2.7× 120 3.4k
Laurie Farrell United States 23 1.5k 2.0× 717 1.6× 304 0.8× 720 2.3× 283 1.4× 34 3.2k
Keisuke Ishizawa Japan 28 643 0.9× 258 0.6× 108 0.3× 115 0.4× 163 0.8× 149 2.5k
Haibin Dai China 28 781 1.0× 101 0.2× 233 0.6× 197 0.6× 316 1.5× 135 2.3k
Maryline Moulin France 24 1.3k 1.7× 269 0.6× 49 0.1× 135 0.4× 164 0.8× 75 2.3k

Countries citing papers authored by Erkki Nissinen

Since Specialization
Citations

This map shows the geographic impact of Erkki Nissinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkki Nissinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkki Nissinen more than expected).

Fields of papers citing papers by Erkki Nissinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkki Nissinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkki Nissinen. The network helps show where Erkki Nissinen may publish in the future.

Co-authorship network of co-authors of Erkki Nissinen

This figure shows the co-authorship network connecting the top 25 collaborators of Erkki Nissinen. A scholar is included among the top collaborators of Erkki Nissinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkki Nissinen. Erkki Nissinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nissinen, Erkki. (2010). Introductory Remarks. International review of neurobiology. 95. 1–5. 5 indexed citations
2.
Nissinen, Erkki & Pekka T. Männistö. (2010). Biochemistry and Pharmacology of Catechol-O-Methyltransferase Inhibitors. International review of neurobiology. 95. 73–118. 32 indexed citations
3.
Sareila, Outi, Riku Korhonen, Mari Hämäläinen, et al.. (2008). Effects of levo‐ and dextrosimendan on NF‐κB‐mediated transcription, iNOS expression and NO production in response to inflammatory stimuli. British Journal of Pharmacology. 155(6). 884–895. 44 indexed citations
4.
Kankaanranta, Hannu, et al.. (2007). Antieosinophilic Activity of Simendans. Journal of Pharmacology and Experimental Therapeutics. 323(1). 31–38. 13 indexed citations
5.
Vendelin, Johanna, et al.. (2004). Novel sulfhydryl-reactive compounds orazipone and OR-1958 inhibit cytokine production and histamine release in rat and human mast cells. International Immunopharmacology. 5(1). 177–184. 8 indexed citations
6.
Vento, Antti, O. J. Rämö, Arto Nemlander, et al.. (1998). Nitecapone inhibits myeloperoxidase in vitro and enhances functional performance after 8 h of ischemia in experimental heart transplantation. Research in Experimental Medicine. 198(6). 299–306. 1 indexed citations
7.
Vento, Antti, et al.. (1997). Nitecapone is of benefit to functional performance in experimental heart transplantation. Research in Experimental Medicine. 197(3). 137–146. 5 indexed citations
8.
Ranta, Sirpa, et al.. (1993). Protection by nitecapone against sodium taurocholate-induced damage to cultured gastric cells. Digestive Diseases and Sciences. 38(4). 701–707. 3 indexed citations
9.
Tarpila, S, et al.. (1991). Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone. European Journal of Clinical Pharmacology. 40(6). 577–580. 18 indexed citations
10.
Kaakkola, Seppo, A. Gordin, Mika Järvinen, et al.. (1990). Effect of a Novel Catechol-O-Methyltransferase Inhibitor, Nitecapone, on the Metabolism of l-Dopa in Healthy Volunteers. Clinical Neuropharmacology. 13(5). 436–447. 38 indexed citations
11.
Schultz, Eija, Erkki Nissinen, & Seppo Kaakkola. (1989). Determination of catechol‐O‐methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection. Biomedical Chromatography. 3(2). 64–67. 46 indexed citations
12.
Nissinen, Erkki, Inge‐Britt Lindén, Eija Schultz, et al.. (1988). Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. European Journal of Pharmacology. 153(2-3). 263–269. 100 indexed citations
13.
Männistö, Pekka T., et al.. (1988). Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models.. PubMed. 38(4A). 598–604. 3 indexed citations
14.
Männistö, Pekka T., Seppo Kaakkola, Erkki Nissinen, Inge‐Britt Lindén, & P Pohto. (1988). Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase. Life Sciences. 43(18). 1465–1471. 54 indexed citations
15.
Nissinen, Erkki, et al.. (1988). Determination of phenol sulphotransferase activity by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 424(1). 136–140. 11 indexed citations
16.
Nissinen, Erkki, et al.. (1987). Determination of cyclic nucleotide phosphodiesterase activity by high-performance liquid chromatography. Analytical Biochemistry. 165(1). 128–132. 8 indexed citations
17.
Rosenberg, Per H., Erkki Nissinen, Pekka T. Männistö, Leena Tuomisto, & James E. Heavner. (1987). Differential effect of tetracaine and bupivacaine on catecholamine and 5-hydroxytryptamine turnover. Pain. 29(2). 239–245. 5 indexed citations
18.
Nissinen, Erkki, et al.. (1984). On-line radiochemical assay for monoamine oxidase utilizing high-performance liquid chromatography. Journal of Pharmacological Methods. 12(4). 247–254. 2 indexed citations
19.
Nissinen, Erkki & Pekka T. Männistö. (1983). Determination of a novel antitussive agent 2′,4′-dimethyl-6′-methoxy-3-(2-methylpiperidyl)-propionaldehyde in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 278(1). 225–227. 1 indexed citations
20.
Bakay, Bohdan, Erkki Nissinen, Lawrence Sweetman, Uta Francke, & William L. Nyhan. (1979). Utilization of Purines by an HPRT Variant in an Intelligent, Nonmutilative Patient with Features of the Lesch-Nyhan Syndrome. Pediatric Research. 13(12). 1365–1370. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuyoshi Nakashima Breakdown of academic impact, for papers by R Warzok Breakdown of academic impact, for papers by J. R. Bianchine Breakdown of academic impact, for papers by D. P. R. Muller Breakdown of academic impact, for papers by Bart Marescau Breakdown of academic impact, for papers by Samuel M. Poloyac Breakdown of academic impact, for papers by Laurie Farrell Breakdown of academic impact, for papers by Keisuke Ishizawa Breakdown of academic impact, for papers by Haibin Dai Breakdown of academic impact, for papers by Maryline Moulin
Rankless by CCL
2026